Office of the Director, National Institutes of Health; Amended Notice of Meeting, 30150 [2014-12079]
Download as PDF
<![CDATA[
sroberts on DSK5SPTVN1PROD with NOTICES
30150
Federal Register / Vol. 79, No. 101 / Tuesday, May 27, 2014 / Notices
7190, Bethesda, MD 20892–7924, 301–435–
2222 copeka@mail.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Pulmonary Hypertension Coordinating
Center.
Date: June 25, 2014.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7192, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Giuseppe Pintucci, Ph.D.
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, Bethesda, MD 20892, 301–435–0287,
Pintuccig@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI T32 Institutional Training Grants.
Date: June 25, 2014.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7189, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Stephanie L Constant,
Ph.D. Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7189, Bethesda, MD 20892, 301–
443–8784, constantsl@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
K23, K24, K25 Research Career Development
Award.
Date: June 26–27, 2014.
Time: 8:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Stephanie J Webb, Ph.D.
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7196, Bethesda, MD 20892, 301–435–0291,
stephanie.webb@nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
NHLBI—Career Development Awards: K01,
K08, K24.
Date: June 26, 2014.
Time: 8:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Crystal City at Reagan
National Airport, 2399 Jefferson Davis Hwy,
Arlington, VA 22202.
Contact Person: Keith A. Mintzer, Ph.D.
Scientific Review Officer, Office of Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7186, Bethesda, MD 20892–7924, 301–594–
7947, mintzerk@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
VerDate Mar<15>2010
21:27 May 23, 2014
Jkt 232001
Dated: May 20, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2014–12080 Filed 5–23–14; 8:45 am]
Office of the Director, National
Institutes of Health; Amended Notice
of Meeting
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 USC,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel Multisite Clinical Trials SEP III.
Date: June 9, 2014.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
DHHS, 6001 Executive Boulevard, Room
4238, MSC 9550, Bethesda, MD 20892, 301–
402–6020, hiromi.ono@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: May 20, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–12084 Filed 5–23–14; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00078
Fmt 4703
Sfmt 4703
National Institutes of Health
Notice is hereby given of a change in
the meeting of the Advisory Committee
to the Director, National Institutes of
Health, June 05, 2014, 09:00 a.m. to June
06, 2014 at 12:00 p.m., National
Institutes of Health, which was
published in the Federal Register on
May 16, 2014, 79FR28529.
The location of the meeting has been
changed from Building 1, Room 126 to
Building 31, 6th Floor, Conference
Room 6. Any interested person may file
written comments with the committee
by forwarding the statement to Gretchen
Wood, Staff Assistant, Office of the
Director, One Center Drive, Building 1,
Room 126, Bethesda, Maryland 20892–
0148, woodgs@od.nih.gov by June 5th at
8:00 a.m. The statement should include
the name, address, telephone number
and, when applicable, the business or
professional affiliation of the interested
person. The meeting is partially closed
to the public.
Dated: May 19, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–12079 Filed 5–23–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel
Phenotypic Manifestations of Copy Number
Variations (CNV).
E:\FR\FM\27MYN1.SGM
27MYN1
]]>Agencies
[Federal Register Volume 79, Number 101 (Tuesday, May 27, 2014)]
[Notices]
[Page 30150]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-12079]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the Advisory
Committee to the Director, National Institutes of Health, June 05,
2014, 09:00 a.m. to June 06, 2014 at 12:00 p.m., National Institutes of
Health, which was published in the Federal Register on May 16, 2014,
79FR28529.
The location of the meeting has been changed from Building 1, Room
126 to Building 31, 6th Floor, Conference Room 6. Any interested person
may file written comments with the committee by forwarding the
statement to Gretchen Wood, Staff Assistant, Office of the Director,
One Center Drive, Building 1, Room 126, Bethesda, Maryland 20892-0148,
woodgs@od.nih.gov by June 5th at 8:00 a.m. The statement should include
the name, address, telephone number and, when applicable, the business
or professional affiliation of the interested person. The meeting is
partially closed to the public.
Dated: May 19, 2014.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-12079 Filed 5-23-14; 8:45 am]
BILLING CODE 4140-01-P
